Details of the Drug Formulaction

General Information of Drug Formulation (ID: F09273)

• Formulation Name: Glipizide 5 mg tablet
• Company: Actavis Pharma; Aphena Pharma Solutions-Tennessee; Bryant Ranch Prepack; Contract Pharmacal; NuCare Pharmaceuticals; PD-Rx Pharmaceuticals; RemedyRepack; State of Florida DOH Central Pharmacy

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Glipizide	(DMZA5PQ)	Diabetic complication	5A2Y	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Carmellose sodium	(E00625)	Not Available	Disintegrant
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Stearic acid	(E00079)	5281	Emulsifying agent; Solubilizing agent; Viscosity-controlling agent; lubricant